<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2016-1S-29-32</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>ИЗМЕНЯЕТСЯ  ЛИ МИНЕРАЛЬНАЯ  ПЛОТНОСТЬ  КОСТИ ПРИ  РАННЕМ  АКСИАЛЬНОМ  СПОНДИЛОАРТРИТЕ?</article-title><trans-title-group xml:lang="en"><trans-title>DOES BONE MINERAL DENSITY CHANGE IN EARLY AXIAL SPONDYLOARTHRITIS?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Губарь</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Gubar</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">gubarelena@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубинина</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubinina</surname><given-names>T. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дёмина</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dyomina</surname><given-names>A. B.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Румянцева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rumyantseva</surname><given-names>O. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шубин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shubin</surname><given-names>S. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Годзенко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Godzenko</surname><given-names>A. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Урумова</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Urumova</surname><given-names>M. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эрдес</surname><given-names>Ш. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Erdes</surname><given-names>Sh. F.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Научно-исследовательский институт ревматологии имени В.А. Насоновой, Москва<country>Россия</country></aff><aff xml:lang="en">V.A. Nasonova Research Institute of Rheumatology, Moscow<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>15</day><month>09</month><year>2016</year></pub-date><volume>54</volume><issue>1S</issue><issue-title>приложение 1</issue-title><fpage>29</fpage><lpage>32</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Губарь Е.Е., Дубинина Т.В., Дёмина А.Б., Румянцева О.А., Шубин С.В., Годзенко А.А., Смирнов А.В., Глухова С.И., Урумова М.М., Эрдес Ш.Ф., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Губарь Е.Е., Дубинина Т.В., Дёмина А.Б., Румянцева О.А., Шубин С.В., Годзенко А.А., Смирнов А.В., Глухова С.И., Урумова М.М., Эрдес Ш.Ф.</copyright-holder><copyright-holder xml:lang="en">Gubar E.E., Dubinina T.V., Dyomina A.B., Rumyantseva O.A., Shubin S.V., Godzenko A.A., Smirnov A.V., Glukhova S.I., Urumova M.M., Erdes S.F.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2249">https://rsp.mediar-press.net/rsp/article/view/2249</self-uri><abstract><p>Частота остеопороза (ОП),  а также механизм  его развития  у больных анкилозирующим спондилитом (АС) и другими спондилоартритами (СпА) изучены недостаточно. Предполагается, что ведущим фактором  ОП при АС является  стойкая воспалительная активность  заболевания.</p><p>Цель – изучить минеральную  плотность  кости (МПК) поясничного отдела (ПО) позвоночника и шейки бедренной  кости (ШБК) у пациентов с ранним  аксиальным СпА (аксСпА) и выявить ее связь с воспалительной активностью заболевания.</p><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 150 пациентов (59 мужчин и 91 женщина) в возрасте от 18 до 45 лет с воспалительной болью в позвоночнике длительностью ≥3 мес и ≤5 лет. Диагноз аксСпА был установлен в соответствии</p></sec><sec><title>с критериями ASAS 2009 г</title><p>с критериями ASAS 2009 г. Для оценки активности использовали индексы BASDAI и ASDAS-СРБ, функционального статуса – BASFI. Обследование включало: определение HLA-B27, рентгенографию таза и ПО позвоночника, магнитно-резонансную томографию (МРТ) крестцово-подвздошных суставов (КПС) и ПО позвоночника, тазобедренных суставов (ТБС; при наличии  клинических признаков их поражения), денситометрию ПО (LI–IV) позвоночника и ШБК. Учитывая молодой возраст пациентов, для оценки МПК использовали Z-критерий. Сниженной МПК считается значение Z-критерия -2 SD и менее хотя бы в одном из исследуемых отделов.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Медиана  Z-критерия составила -0,7 [-1,3; -0,2] SD для шейки бедренной  кости и -0,9 [-1,6; -0,6] SD для ПО позвоночника. Сниженная хотя бы в одном исследуемом отделе МПК  диагностирована у 27 (18,0%) больных. У 21 (14,0%) пациента  имелась сниженная костная  масса в ПО, у 8 (5,3%) – в ШБК.</p><p>У двух (1,3%) больных диагностирована остеопения в двух исследуемых отделах. Не выявлено  ассоциации между снижением МПК  и возрастом,  полом, активностью заболевания (BASDAI, ASDAS-СРБ), лабораторными показателями воспаления (СОЭ, уровень С-реактивного белка – СРБ). Выявлена ассоциация между наличием воспалительных изменений (ВИ) по данным МРТ в ПО позвоночника (МРТ-спондилит) и сниженной МПК хотя бы в одном из исследуемых отделов. МРТ-спондилит был выявлен у 27 (18,0%) больных. Cниженная МПК в любом из исследуемых отделов скелета наблюдалась у 9 (33,3%) из 27 больных, имевших МРТ-спондилит, у остальных 18 (66,7%) были нормальные значения МПК. При отсутствии МРТ-спондилита остеопения определялась  у 18 (14,6%) больных, нормальные показатели  МПК  – у 105 (85,4%; р=0,03).</p><p>Также была выявлена взаимосвязь между наличием  МРТ-спондилита и сниженной МПК  в этом же отделе. Остеопения в ПО выявлена у 7 (25,9%) пациентов с МРТ-спондилитом, а у 20 (74,1%) МПК  ПО оставалась в пределах нормы. При отсутствии МРТ-спондилита остеопения в ПО наблюдалась у 14 (11,4%) пациентов, а у 109 (88,6%) – МПК  ПО была нормальной (р&lt;0,05).</p></sec><sec><title>Заключение</title><p>Заключение. Выявлена  ассоциация между наличием  ВИ в ПО позвоночника по данным МРТ и сниженной МПК  в этом же отделе. Наши данные подтверждают гипотезу о том, что потеря костной  массы в телах позвонков при раннем аксСпА – результат локального  воспаления.</p></sec></abstract><trans-abstract xml:lang="en"><p>The rate of osteoporosis (OP) and the mechanism  of its development in patients with ankylosing spondylitis (AS) and other spondyloarthrititides (SpA) have not been sufficiently investigated. Steady-state  inflammatory disease activity is anticipated  to be the leading factor of OP in AS.</p><sec><title>Objective</title><p>Objective: to investigate lumbar spine (LS) and femoral neck (FN)  bone mineral density (BMD)  in patients with early axial SpA (axSpA) and to reveal its association with inflammatory disease activity.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. A total of 150 patients (59 men and 91 women) aged 18 to 45 years with inflammatory back pain for ≥3 months and ≤5 years were examined. The diagnosis of axSpA was established in accordance  with the 2009 ASAS criteria. BASDAI and ASDAS-CRP were used to assess activity and functional status was evaluated with BASFI. The examination  included determination of HLA-B27, X-ray of the pelvis and LS, magnetic resonance imaging (MRI)  of the sacroiliac joints, LS, and hip joints (in the presence of clinical signs of their involvement),  and densitometry of LS (LI–IV)  and FN. By taking into account the patients’ young age, the Z score was used to estimate BMD. The Z-score -2 SD or lower in at the least one of the regions examined is considered to be diminished BMD. Results and discussion. The median Z-score was -0.7 [-1.3; -0.2] SD for FN and -0.9 [-1.6; -0.6] SD for LS. Reduced BMD in at the least one of the regions examined was diagnosed in 27 (18.0%) patients. There was lower BMD in LS in 21 (14.0%) patients and in FN in 8 (5.3%). Two (1.3%) patients were diagnosed as having osteopenia in the two examined regions. There was no association between diminished BMD and age, gender, disease activity assessed with BASDAI, ASDAS-СRP, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). An association was found between inflammatory LS changes, as evidenced by MRI (MRI spondylitis), and reduced BMD in at least one of the examined regions. MRI spondylitis was detected in 27 (18.0%) patients. Decreased BMD in any of the examined skeletal regions was seen in 9 (33.3%) of the 27 patients having MRI spondylitis; the remaining 18 (66.7%) patients had normal BMD values. In the absence of MRI spondylitis, osteopenia was identified in 18 (14.6%) patients; normal BMD values were noted in 105 (85.4%); p = 0.03). </p><p>There was also a relationship  between the presence of MRI spondylitis and diminished  BMD in the same region. LS osteopenia  was found in 7 (25.9%) patients with MRI spondylitis and LS BMD remained  within the normal range in 20 (74.1%). In the absence of MRI spondylitis, LS osteopenia  was observed in 14 (11.4%) patients and LS BMD was normal in 109 (88.6%) (p &lt; 0.05).</p></sec><sec><title>Conclusion</title><p>Conclusion. There was an association between inflammatory LS changes, as evidenced by MRI,  and reduced BMD in the same region. Our findings confirm the hypothesis that bone mass loss in the vertebral bodies in early axSpA results from local inflammation.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>аксиальный спондилоартрит</kwd><kwd>спондилит  по данным магнитно-резонансной томографии</kwd><kwd>минеральная плотность  кости</kwd></kwd-group><kwd-group xml:lang="en"><kwd>axial spondyloarthritis</kwd><kwd>magnetic resonance imaging spondylitis</kwd><kwd>bone mineral density</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Лесняк ОМ, Беневоленская ЛИ, редакторы. Остеопороз. Диагностика, профилактика и лечение. 2-е изд. Москва: ГЭОТАР-Медиа; 2009. 270 с. [Lesnyak OM, Benevolenskaya LI, editors. Osteoporoz. Diagnostika, profilaktika i lechenie [Osteoporosis. Diagnosis, prevention and treatment]. 2nd ed. Moscow: GEOTAR-Media; 2009. 270 p.].</mixed-citation><mixed-citation xml:lang="en">Лесняк ОМ, Беневоленская ЛИ, редакторы. Остеопороз. Диагностика, профилактика и лечение. 2-е изд. Москва: ГЭОТАР-Медиа; 2009. 270 с. [Lesnyak OM, Benevolenskaya LI, editors. Osteoporoz. Diagnostika, profilaktika i lechenie [Osteoporosis. Diagnosis, prevention and treatment]. 2nd ed. Moscow: GEOTAR-Media; 2009. 270 p.].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001;40:882-8. doi: 10.1093/rheumatology/40.8.882</mixed-citation><mixed-citation xml:lang="en">Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001;40:882-8. doi: 10.1093/rheumatology/40.8.882</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Briot K, Durnez A, Paternotte S, et al. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis. 2013;72(12):1914-9. doi: 10.1136/annrheumdis-2012-201845</mixed-citation><mixed-citation xml:lang="en">Briot K, Durnez A, Paternotte S, et al. Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort. Ann Rheum Dis. 2013;72(12):1914-9. doi: 10.1136/annrheumdis-2012-201845</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haugeberg G, Bennett AN, McGonagle D, et al. Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study. Ann Rheum Dis. 2010;69:1364-6. doi: 10.1136/ard.2009.124982</mixed-citation><mixed-citation xml:lang="en">Haugeberg G, Bennett AN, McGonagle D, et al. Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study. Ann Rheum Dis. 2010;69:1364-6. doi: 10.1136/ard.2009.124982</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bessant R, Keat A. How shoud clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol. 2002;29:1511-9.</mixed-citation><mixed-citation xml:lang="en">Bessant R, Keat A. How shoud clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol. 2002;29:1511-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sarikaya S, Basaran A, Tekin Y, et al. Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol. 2007;13:20-4. doi: 10.1097/01.rhu.0000255688.83037.42</mixed-citation><mixed-citation xml:lang="en">Sarikaya S, Basaran A, Tekin Y, et al. Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis? J Clin Rheumatol. 2007;13:20-4. doi: 10.1097/01.rhu.0000255688.83037.42</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ghozlani I, Ghazi M, Nouijai A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44:772-6. doi: 10.1016/j.bone.2008.12.028</mixed-citation><mixed-citation xml:lang="en">Ghozlani I, Ghazi M, Nouijai A, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44:772-6. doi: 10.1016/j.bone.2008.12.028</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H-R, Kim H-Y, Lee S-H. Elevated serum levels of soluble receptor activator of nuclear factors-κB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Rheumatology. 2006;45:1197-200. doi: 10.1093/rheumatology/kel072</mixed-citation><mixed-citation xml:lang="en">Kim H-R, Kim H-Y, Lee S-H. Elevated serum levels of soluble receptor activator of nuclear factors-κB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS). Rheumatology. 2006;45:1197-200. doi: 10.1093/rheumatology/kel072</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Klingberg E. Clinical study on osteoporosis in ankylosing spondylitis. Dissertation. Gothenburg: Centre for Bone and Arthritis Research Department of Rheumatology and Inflammation Research Sahlgrenska Academy at University of Gothenburg; 2013.</mixed-citation><mixed-citation xml:lang="en">Klingberg E. Clinical study on osteoporosis in ankylosing spondylitis. Dissertation. Gothenburg: Centre for Bone and Arthritis Research Department of Rheumatology and Inflammation Research Sahlgrenska Academy at University of Gothenburg; 2013.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheum. 2011;30(2):269-73. doi: 10.1007/s10067-010-1647-4</mixed-citation><mixed-citation xml:lang="en">Mei Y, Pan F, Gao J, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheum. 2011;30(2):269-73. doi: 10.1007/s10067-010-1647-4</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Maillefert JF, Aho LS, Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int. 2001;12:605-9. doi: 10.1007/s001980170084</mixed-citation><mixed-citation xml:lang="en">Maillefert JF, Aho LS, Maghraoui A, et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int. 2001;12:605-9. doi: 10.1007/s001980170084</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999;42:2319-24. doi:10.1002/1529-0131(199911)42:11&lt;2319::AID-ANR9&gt;3.0.CO;2-G</mixed-citation><mixed-citation xml:lang="en">Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999;42:2319-24. doi:10.1002/1529-0131(199911)42:11&lt;2319::AID-ANR9&gt;3.0.CO;2-G</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rudwaleit M, Landewe R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770-6. doi: 10.1136/ard.2009.108217</mixed-citation><mixed-citation xml:lang="en">Rudwaleit M, Landewe R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770-6. doi: 10.1136/ard.2009.108217</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sieper J, Ruadwaleit M, Baraliakos X, et al. The Assesment of Spondyloarthritis international Society (ASAS) Handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl. II:ii1ii44. doi: 10.1136/ard.2008.104018</mixed-citation><mixed-citation xml:lang="en">Sieper J, Ruadwaleit M, Baraliakos X, et al. The Assesment of Spondyloarthritis international Society (ASAS) Handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl. II:ii1ii44. doi: 10.1136/ard.2008.104018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Official Positions of the International Society for Clinical Densitometry, Copyright ISCD, October 2007, Supersedes all prior «Official Positions» publications.</mixed-citation><mixed-citation xml:lang="en">Official Positions of the International Society for Clinical Densitometry, Copyright ISCD, October 2007, Supersedes all prior «Official Positions» publications.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
